Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02574390 · ClinicalTrials.gov registry record
Answer ALS: Individualized Initiative for ALS Discovery
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 1,049
- Enrollment target
NCT02574390: Completed study, sponsored by Johns Hopkins University.
NCT02574390 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 1,049 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02574390 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 1,049 participants
- Enrollment target
Study Summary
Creation of a large repository of induced pluripotent stem cells (iPSC), bio-fluid samples (blood and spinal fluid (optional)), and cell lines for ALS gene identification. This will be combined carefully with collected measures of the pattern of the symptoms people with ALS have and how these change over time. People with other motor neuron diseases and healthy controls will be included as comparisons
Primary Outcome
12 questions about patient's ability to function in certain activities of daily living. Each question is out of 4 with 4 being normal and 0 being completely impaired.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,049 participants |
| Start Date | 2015-12 |
| Est. Completion | 2020-01-01 |
What the finished NCT02574390 record still lists
NCT02574390 is an observational study that tracks outcomes without assigning an intervention. Its 1,049 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02574390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02574390 about?
NCT02574390 is a clinical study titled "Answer ALS: Individualized Initiative for ALS Discovery". Creation of a large repository of induced pluripotent stem cells (iPSC), bio-fluid samples (blood and spinal fluid (optional)), and cell lines for ALS gene identification. This will be combined carefully with collected measures of the pattern of the symptoms people with ALS have and how these change...
What is the current status of trial NCT02574390?
This trial is currently completed. The enrollment target is 1,049 participants. The study started on 2015-12. Estimated completion is 2020-01-01.
Who is sponsoring clinical trial NCT02574390?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia